Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06523972 · ClinicalTrials.gov registry record
A Study of Cardiovascular Disease Awareness and Cardiovascular Health
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 387
- Enrollment target
NCT06523972: Completed study, sponsored by Mayo Clinic.
NCT06523972 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 387 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06523972 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 387 participants
- Enrollment target
Study Summary
The objective is to increase awareness of various cardiovascular diseases (CVDs) through an interactive, educational experience to promote cardiovascular health (CVH) via an inflatable heart model exhibit and assess community CVD knowledge and whether this experience is an acceptable tool to promote and provide education on CVH.
Primary Outcome
CVH will be measured by LE8 composite score (scale 0-100 points). A higher composite score is associated with ideal cardiovascular health.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 387 participants |
| Start Date | 2024-08-31 |
| Est. Completion | 2024-09-01 |
What the finished NCT06523972 record still lists
NCT06523972 is an observational study that tracks outcomes without assigning an intervention. The registered 387 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06523972 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06523972 about?
NCT06523972 is a clinical study titled "A Study of Cardiovascular Disease Awareness and Cardiovascular Health". The objective is to increase awareness of various cardiovascular diseases (CVDs) through an interactive, educational experience to promote cardiovascular health (CVH) via an inflatable heart model exhibit and assess community CVD knowledge and whether this experience is an acceptable tool to promote...
What is the current status of trial NCT06523972?
This trial is currently completed. The enrollment target is 387 participants. The study started on 2024-08-31. Estimated completion is 2024-09-01.
Who is sponsoring clinical trial NCT06523972?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03761108 · 387 participants · Phase 1
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
- NCT05572632 · 387 participants · NA
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- NCT06917079 · 387 participants · Phase 1
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI